Is Unisound profitable in 2026?

Not yet. Unisound's FY2025 adjusted net loss was RMB 126.5 million, down 24.9% from RMB 168.4 million in 2024, as of December 31, 2025. Losses are narrowing but the company remains unprofitable, and it has raised dilutive equity three times in early 2026 to fund operations.

Who is Unisound's biggest competitor?

iFlytek is Unisound's main rival, estimated to hold roughly 42% of China's voice and NLP market as of March 2026 versus Unisound's much smaller share. iFlytek also launched its Xinghuo X1 model with Huawei on Ascend chips in April 2025, competing in the same healthcare and insurance verticals.

Could AI replace Unisound's core business?

Unisound's original speech recognition business is commoditizing as cloud giants like Alibaba, Baidu, and Huawei absorb voice-to-text into general APIs. The company has responded by pivoting toward vertical large models for hospitals and insurers, where large model revenue hit RMB 610 million in FY2025, over 10x YoY growth.

Unisound IPO'd on the Hong Kong Stock Exchange on June 30, 2025 at HK$205.00 per share. Pre-IPO backers included Qiming Venture Partners and Trustbridge Partners; post-IPO the public reportedly held about 93.8% of shares, per a vendor estimate, with co-founders and Trustbridge retaining stakes.

What is Unisound's revenue growth trend?

Unisound's revenue grew from RMB 939.0 million in 2024 to RMB 1,211.4 million in 2025, up 29.0% YoY, driven largely by large model related business revenue which reached RMB 610 million in 2025, more than 10 times the prior year, per its March 26, 2026 annual results.

Has Unisound diluted shareholders recently?

Yes. Unisound completed three equity placings in five months: January 22, 2026 at HK$252 per share, February 9, 2026 at HK$310 per share, and May 28, 2026 at HK$228 per share (a 19.9% discount), raising a combined roughly HK$880 million in net proceeds for R&D.

AI companies and labs · China

Unisound

unisound.com ↗

Chinese speech AI vendor selling large-model tools to hospitals and insurers.

Losing its protection

Assessed 26 July 2026 · Evidence as of 26 July 2026

The structural protection is eroding.

On the recordSince 26 July 2026 · Checkable from Q3 2026 · Every call on the record Checkpoint: U-series 266B MoE agentic model targeted to ship per company guidance

The call

Unisound is growing fast in narrow, sticky verticals while burning cash and repeatedly diluting shareholders to fund a model race against much bigger rivals.

Unisound makes AI software that listens to patients and doctors, turning speech into text and data for hospitals and insurance companies in China. It has real customers and revenue growing fast, but the basic speech-to-text work is becoming cheaper and easier to buy from cloud services, while iFlytek, a much larger competitor backed by Huawei, is building similar AI models and already selling to the same hospitals and insurers. Unisound is trying to stay ahead by building its own advanced AI model, but that is very expensive and requires lots of money; the company has already raised money three times in five months at lower prices each time, which suggests it is burning through cash quickly and may run out soon.

Why

AI pressure: Generic cloud speech-to-text APIs from Alibaba Cloud, Baidu, Tencent. Basic speech recognition is turning into a cheap cloud API, squeezing the core business Unisound built its name on. Could AI do the core job? Only partly.

Bigger players: iFlytek (Xinghuo X1, built with Huawei on Ascend chips). iFlytek already runs a competing frontier model in the same healthcare and insurance verticals Unisound is chasing, with Huawei's backing and far more scale. Could a giant copy it? Yes, easily.

What protects it. Deep integration inside 100+ hospitals and insurance clients, where compliance and switching costs slow any rival takeover.

What would change this call

iFlytek or Huawei-Ascend models win two or more hospital/insurance contracts Unisound was pursuing. Shows the vertical moat is breakable by a better-funded rival.
A fourth discounted equity placing by Unisound within 12 months of the January 2026 raise. Confirms ongoing cash burn and balance-sheet fragility despite narrowing losses.
Next interim or annual results show large-model revenue growth falling below 2x YoY or losses widening again. Indicates the vertical AI business is losing momentum against competitors.

Key numbers

FY2025 revenue RMB 1.211B, up 29.0% YoY (2025-12-31)
Large-model revenue RMB 610M, up over 10x YoY (2025-12-31)
Third discounted equity placing in 5 months, HK$228/share (2026-05-28)

Named risks

Repeated dilutive equity placings (three in five months, Jan-May 2026) signal ongoing cash burn and balance sheet fragility. Severity: high
Core speech-to-text business commoditizing into cloud APIs from larger rivals like Baidu, Alibaba, Huawei. Severity: high
iFlytek's much larger scale, Huawei/Ascend chip backing, and competing frontier model directly target same hospital and insurance verticals. Severity: high
Still not profitable; adjusted net loss RMB 126.5 million in FY2025 despite narrowing losses. Severity: medium
Extreme stock volatility with 52-week range roughly HK$61 to HK$879, thin trading liquidity. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
iFlytek	losing to	iFlytek estimated near 42% China voice and NLP share vs Unisound's roughly 0.6% overall AI market share, as of March 2026
iFlytek	contesting	iFlytek shipped Xinghuo X1 with Huawei on Ascend chips in April 2025, targeting same healthcare and insurance verticals as Unisound
Baidu	losing to	Baidu's DuerOS and cloud APIs absorb commodity voice recognition work Unisound originally specialized in
Cerence	contesting	iFlytek and Cerence together held over 70% of China's automotive voice market per a 2021-2022 industry report
DeepSeek	losing to	DeepSeek's near-free open weights models cap LLM inference pricing, pressuring Unisound's U2 token pricing strategy in 2026

Questions people ask

Is Unisound profitable in 2026?: Not yet. Unisound's FY2025 adjusted net loss was RMB 126.5 million, down 24.9% from RMB 168.4 million in 2024, as of December 31, 2025. Losses are narrowing but the company remains unprofitable, and it has raised dilutive equity three times in early 2026 to fund operations.
Who is Unisound's biggest competitor?: iFlytek is Unisound's main rival, estimated to hold roughly 42% of China's voice and NLP market as of March 2026 versus Unisound's much smaller share. iFlytek also launched its Xinghuo X1 model with Huawei on Ascend chips in April 2025, competing in the same healthcare and insurance verticals.
Could AI replace Unisound's core business?: Unisound's original speech recognition business is commoditizing as cloud giants like Alibaba, Baidu, and Huawei absorb voice-to-text into general APIs. The company has responded by pivoting toward vertical large models for hospitals and insurers, where large model revenue hit RMB 610 million in FY2025, over 10x YoY growth.
Who owns Unisound?: Unisound IPO'd on the Hong Kong Stock Exchange on June 30, 2025 at HK$205.00 per share. Pre-IPO backers included Qiming Venture Partners and Trustbridge Partners; post-IPO the public reportedly held about 93.8% of shares, per a vendor estimate, with co-founders and Trustbridge retaining stakes.
What is Unisound's revenue growth trend?: Unisound's revenue grew from RMB 939.0 million in 2024 to RMB 1,211.4 million in 2025, up 29.0% YoY, driven largely by large model related business revenue which reached RMB 610 million in 2025, more than 10 times the prior year, per its March 26, 2026 annual results.
Has Unisound diluted shareholders recently?: Yes. Unisound completed three equity placings in five months: January 22, 2026 at HK$252 per share, February 9, 2026 at HK$310 per share, and May 28, 2026 at HK$228 per share (a 19.9% discount), raising a combined roughly HK$880 million in net proceeds for R&D.

Timeline

2026-06-08Unisound released U2 flagship agent model, a 266B total, 10B active MoE model priced at $0.15 to $0.30 per 1M tokens
2026-05-28Third equity placing: 1.7 million H Shares at HK$228, a 19.9% discount, raising about HK$381 million net
2026-03-26FY2025 annual results: revenue RMB 1,211.4 million (+29.0% YoY), adjusted net loss RMB 126.5 million
2026-02-09Second equity placing: 1,008,000 H Shares at HK$310, raising about HK$307.19 million net
2026-01-22First 2026 equity placing: 780,000 H Shares at HK$252, raising about HK$191.69 million net
2025-06-30Unisound IPO on Hong Kong Stock Exchange at HK$205.00 per share, market cap about HK$14.545 billion
2025-05-01Launched U1 InsureMed (Shanhai Zhiyi Huibao) large model for medical insurance compliance and claims
2025-04-01Rival iFlytek launched Xinghuo X1, jointly developed with Huawei on Ascend chips
2019-06-24Company converted to joint-stock company and renamed Unisound AI Technology Co Ltd
2012-06-29Company founded as Beijing Yunzhisheng Information Technology Co Ltd

Head to head

Mobvoi vs Unisound

Revision history

26 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Safe Superintelligence Inc.Mistral AI Cohere